What are the indications, precautions, contraindications, contrast types, common findings, and epidemiology for KUB (plain abdominal radiograph), IVP (intravenous urography), and urethral versus suprapubic catheterization?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Indications, Precautions, and Contraindications for KUB, IVP, and Catheterization

KUB (Kidneys, Ureters, Bladder Radiograph)

Indications

KUB is primarily indicated for detecting radiopaque stones >5mm and monitoring known urolithiasis, though it has largely been superseded by CT for acute presentations 1. The detection rate is 78% for stones >5mm but drops dramatically to only 8% for stones ≤5mm 1. KUB remains useful when combined with ultrasound for follow-up of known stones and in resource-limited settings 2.

Specific clinical scenarios where KUB retains value:

  • Follow-up imaging after stone treatment (combined with ultrasound) 3
  • Monitoring stone growth in known stone formers
  • Pre-operative planning for endourological procedures 4
  • Detecting 90% of radiopaque stones (calcium oxalate, calcium phosphate, struvite) 2

Precautions

  • Body habitus significantly affects sensitivity - obesity reduces stone detection
  • Overlying bowel gas can obscure stones
  • Cannot distinguish phleboliths from ureteral stones on single view
  • Sensitivity varies by stone location: 72% for proximal ureteral stones >5mm, only 29% overall for any size/location 1

Contraindications

  • Pregnancy (relative - minimize radiation exposure)
  • When acute diagnosis is needed (CT is superior)

Common Findings

  • Radiopaque calcifications along expected ureteral course
  • Phleboliths (mimics requiring differentiation)
  • Vascular calcifications
  • Sensitivity: 53-62% for ureteral calculi with specificity 67-69% 2

IVP (Intravenous Pyelography/Urography)

Indications

IVP is now considered obsolete in most settings 2, 4, having been replaced by CT urography. However, limited indications remain:

Specific scenarios where IVP may still be appropriate:

  • Intraoperative assessment in unstable patients when CT unavailable 5
  • Evaluation of pyelocaliceal cavities when CT/MR unavailable 6
  • Congenital urinary tract anomalies 4
  • Pre-endourological procedure planning 4
  • Suspected ureteral fistulas 4
  • Urinary tuberculosis evaluation 4, 7

Contrast Type

Iodinated contrast media (water-soluble, non-ionic preferred - e.g., iobitridol) 8

  • Dose: typically 1 ml/kg body weight
  • Adverse event rate: 0.9% (mostly minor, transient) 8
  • Anaphylactic shock: <0.1% 8

Precautions

High-risk patients require special consideration:

  • Renal insufficiency (creatinine >1.5 mg/dl) - significantly increased adverse reactions 8
  • Previous allergic reactions to contrast (0.8% of patients) 8
  • Pre-existing asthma or allergies (3.7% of patients) - higher adverse event rates 8
  • Females have significantly more contrast-related symptoms than males 8

Contraindications

  • Severe renal failure (relative contraindication)
  • Pregnancy - avoid due to radiation and contrast exposure 2
  • Known severe contrast allergy
  • Acute renal colic when CT available (CT has superior sensitivity/specificity) 1

Performance Characteristics

  • Sensitivity: 75-87% for urolithiasis 1
  • Specificity: 92-94% 1
  • Inferior to CT (sensitivity 85-96%, specificity 98-100%) 1
  • Cannot adequately evaluate renal masses (low sensitivity) 9

Urethral vs Suprapubic Catheterization

Urethral Catheterization

Indications:

  • Acute urinary retention
  • Perioperative bladder drainage (short-term ≤14 days)
  • Accurate urine output monitoring in critically ill
  • Bladder irrigation for hematuria/clots
  • Neurogenic bladder management

Contraindications:

  • Urethral trauma (blood at meatus, high-riding prostate, perineal hematoma) - perform retrograde urethrography first 5
  • Suspected urethral disruption from pelvic fracture
  • Acute prostatitis (relative)
  • Urethral stricture disease (relative)

Complications:

  • Catheter-associated bacteriuria: 2.25 times higher than suprapubic 10
  • Urethral trauma and stricture formation
  • Pain: 5.62 times more common than suprapubic 11
  • Catheter-associated UTI (most common hospital-acquired infection) 10

Suprapubic Catheterization

Indications:

  • Urethral trauma or contraindication to urethral catheterization 5
  • Long-term bladder drainage needs
  • Gynecologic/urologic surgery (common in some centers) 10
  • Patients requiring sexual activity maintenance
  • Failed urethral catheterization

Advantages over urethral:

  • Lower catheter-associated bacteriuria (RR 2.60 for urethral vs suprapubic) 10
  • Reduced urethral trauma/stricture risk
  • Less patient discomfort (RR 2.98 for urethral) 10
  • Allows trial of normal voiding without recatheterization
  • Lower recatheterization rates (RR 4.12 for urethral) 10

Contraindications:

  • Coagulopathy/bleeding disorders (risk of hemorrhage)
  • Distended bowel overlying bladder (risk of bowel perforation)
  • Previous lower abdominal surgery with adhesions
  • Bladder cancer (relative)
  • Pelvic radiation (relative)

Complications:

  • Bowel perforation (can be fatal) 11
  • Bleeding/hematoma
  • Infection at insertion site
  • Urethral leakage despite suprapubic catheter
  • Requires specially trained caregivers for changes 10

Intermittent Catheterization

Advantages:

  • Lower acute urinary retention rates compared to indwelling (RR 0.45) 11
  • Similar bacteriuria rates to indwelling urethral 11
  • Preferred for neurogenic bladder in appropriate patients

Disadvantages:

  • Requires patient dexterity and compliance
  • More patient frustration and difficulty reported 10
  • 45% develop acute retention vs 16% with indwelling 11

Evidence-Based Recommendations for Catheter Choice

For short-term drainage (≤14 days):

  • Suprapubic preferred over indwelling urethral when feasible - reduces bacteriuria, pain, and recatheterization 10, 11
  • Evidence for symptomatic UTI difference is inconclusive 11

For male patients without dementia:

  • External condom catheter preferred when appropriate - 5 times lower risk of bacteriuria/UTI/death (HR 4.84) 10
  • No suitable external catheter exists for women 10

Critical practice point: Always use closed drainage system with needle aspiration ports to reduce catheter-associated infections 10


Epidemiology

Urolithiasis

  • Recurrence rates: 26% in first-time stone formers, up to 53% overall at 5 years 3
  • 90% of stones are radiopaque 2
  • Most common indication for IVP historically: urolithiasis (39.1%), followed by inflammatory diseases (25.6%) and tumors (13.9%) 8

Catheter-Associated Infections

  • Most common hospital-acquired infection 10
  • Bacteriuria develops in majority of patients with indwelling catheters >14 days
  • Symptomatic UTI risk significantly higher with indwelling urethral vs alternatives

References

Guideline

acr appropriateness criteria® hydronephrosis on prior imaging-unknown cause.

Journal of the American College of Radiology, 2024

Research

What is left of i.v. urography?

European radiology, 2001

Guideline

kidney and uro-trauma: wses-aast guidelines.

World Journal of Emergency Surgery, 2019

Research

Computerised tomography and intravenous pyelography in urinary tuberculosis: a retrospective descriptive study.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2015

Research

Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2006

Guideline

acr appropriateness criteria® hematuria.

Journal of the American College of Radiology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.